Chronic community-acquired Acinetobacter pneumonia that responded slowly to rifampicin in the anti-tuberculous regime

Amit Sharma, Malini Shariff, S. S. Thukral, Ashok Shah

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Acinetobacter baumannii is a well-known cause of hospital-acquired pneumonia. Occasionally, it can present as an acute community-acquired pneumonia with a fulminant course. However, the occurrence of the chronic form of community-acquired Acinetobacter pneumonia is yet to be highlighted. We describe a 62-year-old, HIV negative, non-diabetic male, who was referred for evaluation of consolidation and cavitation in the apicoposterior segment of the left upper lobe for 4 months. For this, he had received anti-tuberculous therapy, which included rifampicin. On investigation, a diagnosis of chronic community-acquired pneumonia due to Acinetobacter baumannii was made. The steady clinico-radiologic improvement observed was attributed to rifampicin in the anti-tuberculous regime. Subsequently, an aspergilloma formed in the cavity.

Original languageEnglish
JournalJournal of Infection
Volume51
Issue number3
DOIs
Publication statusPublished - Oct 2005

Fingerprint

Acinetobacter
Rifampin
Pneumonia
Acinetobacter baumannii
HIV
Therapeutics

Keywords

  • Acinetobacter baumannii
  • Aspergilloma
  • Chronic community-acquired pneumonia
  • Non-bacteraemic
  • Rifampicin

ASJC Scopus subject areas

  • Applied Microbiology and Biotechnology
  • Microbiology
  • Parasitology
  • Virology
  • Immunology and Allergy
  • Infectious Diseases

Cite this

Chronic community-acquired Acinetobacter pneumonia that responded slowly to rifampicin in the anti-tuberculous regime. / Sharma, Amit; Shariff, Malini; Thukral, S. S.; Shah, Ashok.

In: Journal of Infection, Vol. 51, No. 3, 10.2005.

Research output: Contribution to journalArticle

@article{86ce3e815f744eaf8341c7439b1bd282,
title = "Chronic community-acquired Acinetobacter pneumonia that responded slowly to rifampicin in the anti-tuberculous regime",
abstract = "Acinetobacter baumannii is a well-known cause of hospital-acquired pneumonia. Occasionally, it can present as an acute community-acquired pneumonia with a fulminant course. However, the occurrence of the chronic form of community-acquired Acinetobacter pneumonia is yet to be highlighted. We describe a 62-year-old, HIV negative, non-diabetic male, who was referred for evaluation of consolidation and cavitation in the apicoposterior segment of the left upper lobe for 4 months. For this, he had received anti-tuberculous therapy, which included rifampicin. On investigation, a diagnosis of chronic community-acquired pneumonia due to Acinetobacter baumannii was made. The steady clinico-radiologic improvement observed was attributed to rifampicin in the anti-tuberculous regime. Subsequently, an aspergilloma formed in the cavity.",
keywords = "Acinetobacter baumannii, Aspergilloma, Chronic community-acquired pneumonia, Non-bacteraemic, Rifampicin",
author = "Amit Sharma and Malini Shariff and Thukral, {S. S.} and Ashok Shah",
year = "2005",
month = "10",
doi = "10.1016/j.jinf.2004.12.003",
language = "English",
volume = "51",
journal = "Journal of Infection",
issn = "0163-4453",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Chronic community-acquired Acinetobacter pneumonia that responded slowly to rifampicin in the anti-tuberculous regime

AU - Sharma, Amit

AU - Shariff, Malini

AU - Thukral, S. S.

AU - Shah, Ashok

PY - 2005/10

Y1 - 2005/10

N2 - Acinetobacter baumannii is a well-known cause of hospital-acquired pneumonia. Occasionally, it can present as an acute community-acquired pneumonia with a fulminant course. However, the occurrence of the chronic form of community-acquired Acinetobacter pneumonia is yet to be highlighted. We describe a 62-year-old, HIV negative, non-diabetic male, who was referred for evaluation of consolidation and cavitation in the apicoposterior segment of the left upper lobe for 4 months. For this, he had received anti-tuberculous therapy, which included rifampicin. On investigation, a diagnosis of chronic community-acquired pneumonia due to Acinetobacter baumannii was made. The steady clinico-radiologic improvement observed was attributed to rifampicin in the anti-tuberculous regime. Subsequently, an aspergilloma formed in the cavity.

AB - Acinetobacter baumannii is a well-known cause of hospital-acquired pneumonia. Occasionally, it can present as an acute community-acquired pneumonia with a fulminant course. However, the occurrence of the chronic form of community-acquired Acinetobacter pneumonia is yet to be highlighted. We describe a 62-year-old, HIV negative, non-diabetic male, who was referred for evaluation of consolidation and cavitation in the apicoposterior segment of the left upper lobe for 4 months. For this, he had received anti-tuberculous therapy, which included rifampicin. On investigation, a diagnosis of chronic community-acquired pneumonia due to Acinetobacter baumannii was made. The steady clinico-radiologic improvement observed was attributed to rifampicin in the anti-tuberculous regime. Subsequently, an aspergilloma formed in the cavity.

KW - Acinetobacter baumannii

KW - Aspergilloma

KW - Chronic community-acquired pneumonia

KW - Non-bacteraemic

KW - Rifampicin

UR - http://www.scopus.com/inward/record.url?scp=27644463510&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27644463510&partnerID=8YFLogxK

U2 - 10.1016/j.jinf.2004.12.003

DO - 10.1016/j.jinf.2004.12.003

M3 - Article

C2 - 16230195

AN - SCOPUS:27644463510

VL - 51

JO - Journal of Infection

JF - Journal of Infection

SN - 0163-4453

IS - 3

ER -